Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage

Status Completed

Clinical Trial Summary

AVERT is a randomized controlled trial comparing video-oculography (VOG)-guided care to standard care to assess accuracy of diagnoses and initial management decisions for emergency department (ED) patients with a chief symptom of vertigo or dizziness suspected to be of vestibular cause. The trial will test the hypothesis that VOG-guided rapid triage (VRT) will accurately, safely, and efficiently differentiate peripheral from central vestibular disorders in ED patients presenting acute vertigo or dizziness, and that doing so has the potential to improve post-treatment clinical outcomes for these patients.

Clinical Trial Description

AVERT is a multicenter, Phase II clinical trial comparing a novel diagnostic strategy (VRT) to standard ED diagnostic care at three performance sites. The Specific Aims are to assess diagnostic accuracy, diagnostic workup costs, and estimate the short-term impact of correct diagnosis in anticipation of a larger, definitive Phase III trial. Adult ED patients with a chief symptom of vertigo, dizziness, or unsteadiness, new or clearly worse in the previous 30 days, will undergo on-site vestibular function tests by trained research personnel using a portable, quantitative VOG recording device. Research personnel will also record a focused symptom history and bedside hearing tests. Eligible patients with at least one pathologic vestibular eye movement finding or pathologic ataxia will be randomized to VRT or standard ED care. Patients eligible for pre-randomization testing but excluded from randomization will be slated for the Observational Arm of the study and will undergo limited 1 and 6 month phone follow-up. The VRT arm relies on an automated algorithm to interpret VOG results, thereby determining a patient-specific clinical care pathway. For safety, all VRT-arm study subjects will undergo stroke protocol MRI before release. All randomized subjects will undergo confirmatory testing at one week, including vestibular specialist exam and 1.5 or 3-Tesla research MRI combining stroke and internal auditory canal protocols. All randomized patients will also undergo 1 month and 6 month phone follow-up and medical record review to confirm diagnoses. Clinical findings, ED diagnoses, diagnostic resource utilization, treatments applied, and clinical events during follow-up will be recorded. A multidisciplinary, masked, expert panel will adjudicate final diagnoses. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02483429
Study type	Interventional
Source	Johns Hopkins University
Contact
Status	Completed
Phase	Phase 2
Start date	December 4, 2017
Completion date	March 17, 2023

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04196933` - Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma	N/A
Completed	`NCT05427097` - Thermal Energy in the Treatment of Cervicogenic Dizziness	N/A
Completed	`NCT02299128` - Effectiveness of Early Physical Therapy Intervention for Patients With Dizziness After a Sports-Related Concussion	N/A
Completed	`NCT02733549` - Is The Sudden Onset of Dizziness A Symptom of Acute Liver Dysfunction?	N/A
Completed	`NCT05812209` - Stellate Ganglion Block to Treat Long COVID 19 Case Series
Not yet recruiting	`NCT03973658` - Dizziness Among First Time Users of Hearing Aids
Completed	`NCT03182868` - Vestibular Testing: Consistency and Effects Over Time	N/A
Completed	`NCT02938221` - Telemedical Examination of a Three-Component Oculomotor Testing Battery	N/A
Active, not recruiting	`NCT02655575` - Assessment and Treatment of Patients With Long-term Dizziness in Primary Care	N/A
Completed	`NCT02772042` - Traction Manipulation of Upper Cervical Spine on Cervicogenic Dizziness	N/A
Completed	`NCT00732797` - A Trial of Booklet Based Self Management of Dizziness	N/A
Not yet recruiting	`NCT06010550` - Validating a Clinical Decision Support Tool for Stratifying Stroke Risk for Dizziness/Vertigo
Recruiting	`NCT03618199` - Efficacy of a Transcranial Vibrating System for Minimizing Dizziness During Caloric Testing	N/A
Completed	`NCT03330262` - Head-Mounted Vibrotactile Prosthesis for Patients With Chronic Postural Instability	N/A
Completed	`NCT05157399` - Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness	N/A
Completed	`NCT02344446` - Physical Therapy Intervention for Extended Physical Symptoms After a Sports-related Concussion	N/A
Withdrawn	`NCT00732108` - Is Topiramate Effective in Treating Dizziness in Patient's With Migraine-Associated Dizziness	N/A
Active, not recruiting	`NCT05122663` - Emergency Department Vestibular Rehabilitation Therapy for Dizziness and Vertigo
Recruiting	`NCT05634902` - Implementation of Evidence-Based Practice for Dizziness	N/A
Completed	`NCT02640599` - Stationary Bike Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage (AVERT) — AVERT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms